Last updated: 19 July 2019 at 7:14am EST

Mark Robert Baker Net Worth




The estimated Net Worth of Mark Robert Baker is at least $689 Thousand dollars as of 27 March 2013. Mark Baker owns over 650 units of Progenics Pharmaceuticals stock worth over $660,678 and over the last 19 years Mark sold PGNX stock worth over $28,171.

Mark Baker PGNX stock SEC Form 4 insiders trading

Mark has made over 52 trades of the Progenics Pharmaceuticals stock since 2006, according to the Form 4 filled with the SEC. Most recently Mark bought 650 units of PGNX stock worth $3,458 on 27 March 2013.

The largest trade Mark's ever made was buying 49,793 units of Progenics Pharmaceuticals stock on 16 November 2012 worth over $90,623. On average, Mark trades about 3,735 units every 41 days since 2005. As of 27 March 2013 Mark still owns at least 161,141 units of Progenics Pharmaceuticals stock.

You can see the complete history of Mark Baker stock trades at the bottom of the page.



Insiders trading at Progenics Pharmaceuticals

Over the last 21 years, insiders at Progenics Pharmaceuticals have traded over $11,559,939 worth of Progenics Pharmaceuticals stock and bought 2,672,016 units worth $11,900,148 . The most active insiders traders include Healthcare Master Fund Ltd ..., Michael D Kishbauch, and Bradley L Campbell. On average, Progenics Pharmaceuticals executives and independent directors trade stock every 16 days with the average trade being worth of $60,241. The most recent stock trade was executed by Capital, L.P.Altiva Managem... on 9 September 2019, trading 72,023 units of PGNX stock currently worth $359,395.



What does Progenics Pharmaceuticals do?

Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon in 1986 and is headquartered in New York, NY.



What does Progenics Pharmaceuticals's logo look like?

Progenics Pharmaceuticals, Inc. logo

Complete history of Mark Baker stock trades at Progenics Pharmaceuticals

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
27 Mar 2013 Mark Robert Baker
CEO
Buy 650 $5.32 $3,458
27 Mar 2013
161,141
27 Feb 2013 Mark Robert Baker
CEO
Buy 1,262 $2.72 $3,433
27 Feb 2013
160,491
22 Jan 2013 Mark Robert Baker
CEO
Buy 1,215 $2.82 $3,426
22 Jan 2013
159,229
26 Dec 2012 Mark Robert Baker
CEO
Buy 1,142 $3.01 $3,437
26 Dec 2012
158,014
28 Nov 2012 Mark Robert Baker
CEO
Buy 1,607 $2.13 $3,423
28 Nov 2012
156,872
19 Nov 2012 Mark Robert Baker
CEO
Buy 11,800 $1.96 $23,128
19 Nov 2012
155,265
16 Nov 2012 Mark Robert Baker
CEO
Buy 49,793 $1.82 $90,623
16 Nov 2012
143,465
15 Nov 2012 Mark Robert Baker
CEO
Buy 48,833 $1.69 $82,528
15 Nov 2012
93,672
24 Oct 2012 Mark Robert Baker
CEO
Buy 1,162 $2.96 $3,440
24 Oct 2012
44,839
26 Sep 2012 Mark Robert Baker
CEO
Buy 1,036 $3.32 $3,440
26 Sep 2012
43,677
22 Aug 2012 Mark Robert Baker
CEO
Buy 815 $4.23 $3,447
22 Aug 2012
42,641
25 Jul 2012 Mark Robert Baker
CEO
Buy 346 $10.04 $3,474
25 Jul 2012
41,826
27 Jun 2012 Mark Robert Baker
CEO
Buy 375 $9.27 $3,476
27 Jun 2012
41,480
23 May 2012 Mark Robert Baker
CEO
Buy 445 $7.81 $3,475
23 May 2012
41,105
25 Apr 2012 Mark Robert Baker
CEO
Buy 348 $10.07 $3,504
25 Apr 2012
40,660
28 Mar 2012 Mark Robert Baker
CEO
Buy 343 $10.13 $3,475
28 Mar 2012
40,312
22 Feb 2012 Mark Robert Baker
CEO
Buy 369 $9.41 $3,472
22 Feb 2012
39,969
25 Jan 2012 Mark Robert Baker
CEO
Buy 364 $9.53 $3,469
25 Jan 2012
39,600
23 Nov 2011 Mark Robert Baker
CEO
Sale 634 $5.45 $3,455
23 Nov 2011
38,313
26 Oct 2011 Mark Robert Baker
CEO
Buy 923 $7.51 $6,932
26 Oct 2011
39,236
3 Oct 2011 Mark Robert Baker
CEO
Option 5,124 $4.62 $23,673
3 Oct 2011
42,345
28 Sep 2011 Mark Robert Baker
CEO
Buy 542 $6.39 $3,463
28 Sep 2011
37,029
24 Aug 2011 Mark Robert Baker
CEO
Buy 571 $6.08 $3,472
24 Aug 2011
36,487
27 Jul 2011 Mark Robert Baker
CEO
Buy 567 $6.12 $3,470
27 Jul 2011
35,916
1 Jul 2011 Mark Robert Baker
CEO
Option 20,032 $5.46 $109,375
1 Jul 2011
52,254
22 Jun 2011 Mark Robert Baker
CEO
Buy 490 $7.08 $3,469
22 Jun 2011
31,922
25 May 2011 Mark Robert Baker
CEO
Buy 486 $7.13 $3,465
25 May 2011
31,432
27 Apr 2011 Mark Robert Baker
CEO
Buy 479 $7.24 $3,468
27 Apr 2011
30,946
1 Apr 2011 Mark Robert Baker
CEO
Option 4,022 $5.05 $20,311
1 Apr 2011
34,017
3 Jan 2011 Mark Robert Baker
CEO
Option 4,377 $4.83 $21,141
3 Jan 2011
33,765
1 Oct 2010 Mark Robert Baker
CEO
Option 17,545 $4.32 $75,794
1 Oct 2010
45,158
1 Jul 2010 Mark Robert Baker
CEO
Option 4,575 $4.44 $20,313
1 Jul 2010
31,503
22 Jun 2010 Mark Robert Baker
CEO
Sale 2,328 $5.66 $13,176
22 Jun 2010
26,689
1 Apr 2010 Mark Robert Baker
CEO
Option 4,300 $4.56 $19,608
1 Apr 2010
32,930
18 Mar 2010 Mark Robert Baker
CEO
Sale 2,165 $5.33 $11,539
18 Mar 2010
28,423
4 Jan 2010 Mark Robert Baker
CEO
Option 4,720 $3.78 $17,842
4 Jan 2010
34,883
1 Oct 2009 Mark Robert Baker
CEO
Option 3,999 $4.26 $17,036
1 Oct 2009
33,554
1 Jul 2009 Mark Robert Baker
CEO
Option 13,207 $5.33 $70,393
1 Jul 2009
41,363
1 Apr 2009 Mark Robert Baker
CEO
Option 3,180 $5.65 $17,967
1 Apr 2009
27,942
2 Jan 2009 Mark Robert Baker
CEO
Option 2,033 $9.13 $18,561
2 Jan 2009
29,336
1 Oct 2008 Mark Robert Baker
CEO
Option 2,393 $6.53 $15,626
1 Oct 2008
28,827
1 Jul 2008 Mark Robert Baker
CEO
Option 4,865 $13.64 $66,359
1 Jul 2008
30,352
1 Apr 2008 Mark Robert Baker
CEO
Option 2,533 $6.52 $16,515
1 Apr 2008
27,722
2 Jan 2008 Mark Robert Baker
CEO
Option 916 $15.33 $14,042
2 Jan 2008
25,854
1 Oct 2007 Mark Robert Baker
CEO
Option 748 $19.03 $14,234
1 Oct 2007
25,558
2 Jul 2007 Mark Robert Baker
CEO
Option 3,451 $18.71 $64,568
2 Jul 2007
27,900
2 Apr 2007 Mark Robert Baker
CEO
Option 621 $20.13 $12,501
2 Apr 2007
11,625
3 Jan 2007 Mark Robert Baker
CEO
Option 571 $21.88 $12,493
3 Jan 2007
11,463
2 Oct 2006 Mark Robert Baker
CEO
Option 627 $19.58 $12,277
2 Oct 2006
11,412
3 Jul 2006 Mark Robert Baker
CEO
Option 3,056 $25.01 $76,431
3 Jul 2006
5,506
3 Apr 2006 Mark Robert Baker
CEO
Option 500 $21.77 $10,885
3 Apr 2006
2,856
3 Jan 2006 Mark Robert Baker
CEO
Option 539 $20.86 $11,244
3 Jan 2006
2,793


Progenics Pharmaceuticals executives and stock owners

Progenics Pharmaceuticals executives and other stock owners filed with the SEC include: